You are here: Industry Insights > Market News > Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

SG-DJ10 Capsule and Tablet Sample Checkweigher

NADP+

NMN

Ceritinib (LDK378) CAS:1032900-25-6

SG-JN10 0.1mg Tablet Capsule Check Weigher

β-Nicotinamide Adenine Dinucleotide (NAD+)

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope

expresspharmaJune 08, 2020

Tag: Remdesivir , Maharashtra , coronavirus , COVID-19

Favorites

The Maharashtra government will procure 10,000 vials of the drug Remdesivir for treating coronavirus patients, informed Rajesh Tope, Public Health Minister.

The expensive medicine is being made available for the poor and needy patients in the state, he said.

“GoM to procure 10k vials of remdesivir. Based on evidence from laboratory, animal and clinical studies, it has generated promising results in MERS-CoV and SARS which are also caused by coronavirus,” Tope tweeted.

“WHO suggests it may have some positive effects on COVID-19 treatment. This expensive medicine is being made available for poor & needy patients,” he added.

Previous:Ministry of Health publishes draft New Drugs and Clinical Trials (Amendment) Rules

Next:Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

PharmaSourcesNovember 15, 2024

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope | Pharmasources.com

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform, announced today the appointment of Dr. Elisabeth Lackner to its Supervisory Board.

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope

Related News

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

You may like
More>>

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope

Related News

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

You may likeMore>>

You may like
More>>